subject: Global Alzheimer Drugs Market: An Analysis - Market Research Reports On Aarkstore Enterprise [print this page] The Alzheimers disease (AD) diagnosis and therapy market is expanding with increasing number of cases worldwide. The current scenario shows bright outlook for diagnosis market. As early diagnosis of AD is not possible, there is a strong need of an early detection technique. United States, Europe and Japan are the three major markets for the treatment of AD. In China, the diagnosis and drug treatment of Alzheimers disease is extremely low, which represents a potential opportunity for market players.
The worldwide Alzheimer disease market is led by sales of Eisai/Pfizer and Aricept. Eisai/Pfizers Aricept (donepezil) and Forest pharmaceuticals Namenda (memantine) are the market leaders in the United States. After cardiovascular diseases and cancer, AD is the third largest market in the world in terms of cost of treatment of the disease.
Aging population is a major cause of increasing number of Alzheimer patients and driving AD diagnosis and treatment market. Urbanization also contributes to the growing AD market. The unmet clinical needs are driving competitors to focus on R&D which ultimately leads to new product introduction and helps in market growth.
The present report analyzes Alzheimers disease treatment and diagnosis market and discusses major drugs being used for the treatment of AD in United States, Japan and China. It analyses major growth drivers and opportunities present in the market. The report also discusses competition prevailing in the industry and an overview of the leading companies and their business strategies. The section on market forecast helps market players to develop business strategies accordingly.
Table of Contents :
1. Introduction
Types of Prescription Medications
1.1 Industry Facts
2. Alzheimer Drugs Market
2.1 Worldwide Alzheimer Drug Market
Global Market Value
Growth Rate
Market Value by Drugs
Market Share
2.2 Alzheimers Market: United States
Market Value
Market Share
2.3 China Alzheimer Market
3. Market Features
3.1 Key Trends
3.1.1 Dementia Prevailing in Aging People
3.1.2 Urbanization and Gender Differences
3.1.3 East-West differences
3.2 Market Opportunities
Unmet Clinical Needs
Opportunity in Diagnosis Market
Increasing Cases in Europe
3.3 Significant Developments
RFID Chip Implants
Herbal supplement improves memory
Blood Test to Detect Alzheimer's disease
4. Competitive Landscape
4.1 Drug Competition
4.2 Leading Players
5. Company Profiles
5.1 Forest Laboratories
Overview
Business Strategies
Comprehensive Set of Products
Limited Geographical Presence/Narrow Customer Base
